FDA Publishes First Annual Report on Postmarketing Commitment Studies for Drug and Biologics Firms

Summary

The Food and Drug Administration (FDA) has released its first annual report on the status of postmarketing study commitments made by sponsors of approved drug and biologics products, as mandated by the Food and Drug Administration Modernization Act of 1997.